Lipids and lipoprotein (a) concentrations in Pakistani patients with type 2 diabetes mellitus

Diabetes, Obesity and Metabolism

Volumn 6, Issue 5, 2004, Pages 338-343

  Habib, Syed Shahid ^a,b   Aslam, M ^a  

^a ARMY MEDICAL COLLEGE   (Pakistan)

^b KING SAUD UNIVERSITY   (Saudi Arabia)

Author keywords

Diabetes mellitus; Dyslipidaemias; Lipoproteins (a); Lipoproteins glycosylated haemoglobin

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPOPROTEIN A; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; ARTICLE; BLOOD SAMPLING; BODY MASS; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CORRELATION ANALYSIS; CORRELATION COEFFICIENT; DIASTOLIC BLOOD PRESSURE; DISEASE ASSOCIATION; FEMALE; HUMAN; LIPID BLOOD LEVEL; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PAKISTAN; RISK FACTOR; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 4444366225     PISSN: 14628902     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1462-8902.2004.00352.x     Document Type: Article

References (32)

1. Mooradian AD. Cardiovascular disease in type 2 diabetes mellitus: current management guidelines. Arch Intern Med 2003; 163 (1): 33-40.
2. Gruddy SM, Benjamin IJ, Burke GL. Diabetes and cardiovascular Disease. A statement for health care professionals from the American Heart Association. Circulation 1999; 100: 1134-1146.
3. Goldberg IJ. Diabetic dyslipidemia: causes consequences. J Clin Endocrinol Metab 2001; 86 (3): 965-971.
4. Grundy SM. Small LDL, atherogenic dyslipidemia, and the metabolic syndrome. Circulation 1997; 95: 1-4.
5. Tamborlane WV, Ahern J. Implications and results of the Diabetes Control and Complications Trial. Pediatr Clin North Am 1997; 44 (2): 285-300.
6. Turner R, Cull C, Holman R. United Kingdom Prospective Diabetes Study 17: a 9-year update of a randomized, controlled trial on the effect of improved metabolic control on complications in non-insulin-dependent diabetes mellitus. Ann Intern Med 1996; 124 (1 Part 2): 136-145.
7. Stratton IM, Adler AI, Neil HA et al. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. BMJ 2000; 321 (7258): 405-412.
8. Expert panel on detection, Evaluation and treatment of High Blood Cholesterol in Adults, National Cholesterol Education Program. Second report of the Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol (Adult Treatment Panel II). Circulation 1994; 89: 1333-1445.
9. Maher VM, Brown BG, Marcovina SM, Hillger LA, Zhao XQ, Albers JJ. Effects of lowering LDL cholesterol on the cardiovascular risk of lipoprotein (a). JAMA 1995; 274 (22): 1771-1774.
10. Lamarche B, Tehernof A, Moorjani S et al. Small dense low density lipoprotein particles as a predictor of the risk of ischemic heart disease in men. Circulation 1997; 95: 69-75.
11. Ernest B, Marshall LA, Barry CS, Thomas KJ, Seligsohn W. Vascular functions in hemostasis: Lipoprotein (a) and fibrinolytic assembly. In: Beck WS ed., Hematology, 6th edn. New York: McGraw Hill, 2001; 1451-1470.
12. Woo J, Lam CWK, Kay R, Woing HY, Teoh R, Nicholls MG. Acute and long term changes in serum lipids after acute stroke. Stroke 1990; 21: 1407-1411.
13. Kostner KM, Kostner GM. Lipoprotein (a): still an enigma? Curr Opin Lipidol 2002; 13: 391-396.
14. Bartens W, Rader DJ, Talley G, Brewer HB Jr. Lipoprotein (a) in patients with hyperlipidaemia. Eur J Clin Invest 1995; 25 (9): 647-653.
15. Slunga L, Johnson O, Dahlen Gh, Eriksson S. Lipoprotein (a) and acute phase proteins in acute myocardial infarction. Scand J Clin Lab Invest 1992; 52: 95-101.
16. Farish E, Rolton HA, Barnes JF, Hart DM. Lipoprotein (a) concentrations in postmenopausal women taking norethisterone. BMJ 1991; 303: 694.
17. Shlipak MG, Simon JA, Vittinghof E, Conner EB, Knop RH. Estrogen and progestin, Lipoprotein (a), and the risk of recurrent coronary heart disease after menopause. JAMA 2000; 12 (5): 242-248.
18. Ramirez LC, Arauz-Pacheco C, Lackner C, Albright G, Adams BV, Raskin P. Lipoprotein (a) levels in diabetes mellitus: relationship to metabolic control. Ann Intern Med 1992; 117: 42-47.
19. White AL, Rainwater DL, Lanford RE. Intracellular maturation of apolipoprotein (a) and assembly of lipoprorein (a) in primary baboon hepatocytes. J Lipid Res 1993; 34 (3): 509-517.
20. Parhofer KG, Demant T, Ritter MM, Geiss HC, Markus Donner M, Schwandt P. Lipoprotein (a) metabolism estimated by nonsteady-state kinetics. Lipids 1999; 34 (4): 325-335.
21. Rader DJ, Mann WA, Cain W et al. The low density lipoprotein receptor is not required for normal catabolism of Lp(a) in humans. J Clin Invest 1995; 95 (3): 1403-1408.
22. Rader DJ, Cain W, Ikewaki K et al. The inverse association of plasma lipoprotein (a) concentrations with apolipoprotein (a) isoform size is not due to differences in Lp(a) catabolism but to differences in production rate. J Clin Invest 1994; 93 (6): 2758-2763.
23. Klaya F, Durlach V, Bertin E, Monier F, Monboisse JC, Gillery P. Evaluation of serum glycated lipoprotein(a) levels in non insulin-dependent diabetic patients. Clin Biochem 1997; 30 (3): 227-230.
24. Wieringa G. Lipoiprotein(a): what's in a measure. Ann Clin Biochem 2000; 37: 571-580.
25. Rigla M, Sanchez-Quesada JL, Ordonez-Lianos J et al. Effect of physical exercise on lipoprotein (a) and low-density lipoprotein modifications in type I and type 2 diabetic patients. Metabolism 2000; 49 (5): 640-647.
26. Chico A, Perez A, Caixas A, Ordonez J, Pou JM, Leiva A. Lipoprotein(a) concentrations and non-insulin-dependent diabetes mellitus: relationship to glycaemic control and diabetic complications. Diabetes Res Clin Pract 1996; 33 (2): 105-110.
27. Kronenberg F, Kronenberg MF, Kiechl S et al. Role of lipoprotein(a) and apolipoprotein(a) phenotype in atherogenesis: prospective results from the Bruneck study. Circulation 1999; 100: 1154-1160.
28. Chang CJ, Kao JT, Wu TJ, Lu FH, Tai TY. Serum lipids and lipoprotein (a) concentrations in Chinese NIDDM patients. Diabetes Care 1995; 18 (8): 1191-1194.
29. Chi J, Tang W, Sun M. Lipoprotein (a) and non-insulin dependent diabetes mellitus. Zhonghua Nei Ke Za Zhi 1996; 35 (4): 246-248.
30. Rainwater DL. Lp(a) concentrations are related to plasma lipid concentrations. Atherosclerosis 1996; 127: 13-18.
31. Rainwater DL, MacCluer JW, Stern MP, VandeBerg JL, Haffner SM. Effects of NIDDM on lipoprotein(a) concentration and apolipoprotein(a) size. Diabetes 1994; 43 (7): 942-946.
32. Wassef GN. Lipoprotein(a) in android obesity and NIDDM: a new member in 'the metabolic syndrome'. Biomed Pharmacother 1999; 53 (10): 462-465.